Self-deception around substance use, including cannabis, can create physiological stress responses that may interfere with therapeutic outcomes. Understanding these mind-body connections helps clinicians recognize when patients may be minimizing their use patterns or treatment responses.
Research demonstrates that self-deceptive behaviors trigger measurable physiological changes, including altered autonomic nervous system responses and stress markers. The body appears to register internal conflicts between conscious beliefs and actual behaviors, even when individuals are not consciously aware of the deception. This physiological response may reflect deeper psychological processes that can influence treatment adherence and therapeutic relationships.
“I see this regularly in cannabis medicine — patients who underreport their use often show signs of internal conflict that their physiology betrays. The body keeps score even when the mind tries to edit the narrative.”
💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it:
Table of Contents
FAQ
This article has been assigned CED Clinical Relevance #70, indicating “Notable Clinical Interest.” This rating suggests the content contains emerging findings or policy developments that healthcare providers should monitor closely.
What clinical areas does this cannabis news impact?
The article covers several key clinical domains including patient communication, clinical assessment, and therapeutic relationships. It also touches on behavioral medicine aspects related to cannabis use and treatment.
Why is this cannabis news considered “emerging”?
The article is marked as “New” and focuses on recent developments in cannabis-related healthcare. These emerging findings represent evolving understanding or policy changes that may influence clinical practice.
How should healthcare providers use this information?
Providers should monitor these developments closely as they may impact patient care protocols. The information can help inform therapeutic relationships and improve patient communication regarding cannabis use.
What makes this cannabis news clinically significant?
The designation of “Notable Clinical Interest” indicates this information goes beyond routine updates. It represents findings or developments that could meaningfully influence clinical decision-making or patient management strategies.